StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Acumen Pharmaceuticals, Inc.
NasdaqGS:ABOS
Sector
Location
Market Cap
USD 73.29 M
Share Price
USD 1.21
Avg Daily Volume
336,868
Change (1 day)
4.31%
Change (1 year)
-47.62%
Change (YTD)
-29.65%
Acumen Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -102.48 M
Acumen Pharmaceuticals, Inc. Operating Cash Flow is USD -102.48 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 101.93% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Acumen Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -50.75 M, a 37.05% change year over year.
-
Acumen Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -37.03 M, a 55.00% change year over year.
-
Acumen Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -23.89 M.
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 130.84
MRK.DE
+2.82
2.20%
Tempus AI, Inc.
USD 58.51
TEM
+0.50
0.86%
Apogee Therapeutics, Inc.
USD 36.41
APGE
-2.83
-7.21%
Twist Bioscience Corporation
USD 36.98
TWST
+1.39
3.91%
Schrödinger, Inc.
USD 21.42
SDGR
+0.79
3.83%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Thermo Fisher Scientific Inc.
USD 426.17
TMO
+7.47
1.78%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 130.84
MRK.DE
+2.82
2.20%
Tempus AI, Inc.
USD 58.51
TEM
+0.50
0.86%
Apogee Therapeutics, Inc.
USD 36.41
APGE
-2.83
-7.21%
Twist Bioscience Corporation
USD 36.98
TWST
+1.39
3.91%
Schrödinger, Inc.
USD 21.42
SDGR
+0.79
3.83%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Thermo Fisher Scientific Inc.
USD 426.17
TMO
+7.47
1.78%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%